October 24, 2021

Ac-Devd-AFC

Ac-Devd-AFC 

To Order Contact us: bjorn@lembcke.dk

Ac-DEVD-AFC
C5524-5 5 mg
EUR 241
Description: Ac-DEVD-AFC is a fluorogenic substrate for activated caspase-3 (CPP32) with Km value of 9.7 ?M, and related cysteine proteases [1][2].

Ac-DEVD-AFC
HY-P1005 10mg
EUR 436

Ac-DEVD-AFC *CAS 201608-14-2*
13401 5 mg
EUR 132
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

Z-DEVD-AFC
A8753-25 25 mg
EUR 456
Description: Z-DEVD-AFC is a fluorometric substrate for caspase-3 (Km = 9.7µM) and other related caspases. The sequence DEVD is based on PARP cleavage at Asp216 for caspase-3.

Z-DEVD-AFC
A8753-5 5 mg
EUR 166
Description: Z-DEVD-AFC is a fluorometric substrate for caspase-3 (Km = 9.7µM) and other related caspases. The sequence DEVD is based on PARP cleavage at Asp216 for caspase-3.

Ac-DEVD-CHO
B1951-1
EUR 142

Ac-DEVD-CHO
B1951-5
EUR 414

Ac-DEVD-CMK
C5528-1 1 mg
EUR 139
Description: Ac-DEVD-CMK is a cell-permeable and irreversible caspase-3 inhibitor [1][2][3]. Apoptosis is a process of programmed cell death that occurs in multicellular organisms.

Ac-DEVD-CMK
C5528-5 5 mg
EUR 457
Description: Ac-DEVD-CMK is a cell-permeable and irreversible caspase-3 inhibitor [1][2][3]. Apoptosis is a process of programmed cell death that occurs in multicellular organisms.

Ac-DEVD-pNA
A8744-25 25 mg
EUR 282
Description: Ac-DEVD-pNA is a colorimetric substrate for caspase-3 (Km=9.7µM) and caspases-1, -4, -6, and -7 [1]. Ac is the acetyl group and pNA is p-nitroanilide. Sequence is based on PARP (poly(ADPribose) polymerase) cleavage site Asp216 for caspase-3

Ac-DEVD-pNA
A8744-5 5 mg
EUR 119
Description: Ac-DEVD-pNA is a colorimetric substrate for caspase-3 (Km=9.7µM) and caspases-1, -4, -6, and -7 [1]. Ac is the acetyl group and pNA is p-nitroanilide. Sequence is based on PARP (poly(ADPribose) polymerase) cleavage site Asp216 for caspase-3

Ac-DEVD-CHO
HY-P1001 5mg
EUR 380

Ac-DEVD-AMC
HY-P1003 5mg
EUR 257

Ac-DEVD-pNA
HY-P1006 25mg
EUR 449

Caspase-3 Substrate DEVD-AFC
1007-1000
EUR 642

Caspase-3 Substrate DEVD-AFC
1007-200
EUR 327

Ac-WEHD-AFC
B2214-25
EUR 675

Ac-WEHD-AFC
B2214-5
EUR 207

Ac-IEPD-AFC
B2526-25
EUR 838

Ac-IEPD-AFC
B2526-5
EUR 251

Ac-IEPD-AFC
A4418-5 5 mg
EUR 324
Description: Peptide sequence shown to be preferred recognition motif for the serine protease granzyme B. Fluorogenic substrate.

Ac-LEHD-AFC
A4419-10 10 mg
EUR 355
Description: Fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC.

Ac-LEHD-AFC
A4419-5 5 mg
EUR 216
Description: Fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC.

Ac-VEID-AFC
A8751-25 25 mg
EUR 456
Description: Ac-VEID-AFC is a fluorogenic substrate of caspase-6 (Km=30?M; Kcat/Km=168000 M-1sec-1) and related cysteine proteases. The sequence is based on the lamin A site of cleavage.

Ac-VEID-AFC
A8751-5 5 mg
EUR 166
Description: Ac-VEID-AFC is a fluorogenic substrate of caspase-6 (Km=30?M; Kcat/Km=168000 M-1sec-1) and related cysteine proteases. The sequence is based on the lamin A site of cleavage.

Ac-IETD-AFC
A8752-25 25 mg
EUR 456
Description: Ac-IETD-AFC is a fluorogenic substrate of caspase-8 and possesses amino aicd sequence IETD which is recognized by caspase-8-mediated proteolysis. It is also a substrate for caspase-3 processing enzyme, caspase-10, and granzyme B.

Ac-IETD-AFC
A8752-5 5 mg
EUR 166
Description: Ac-IETD-AFC is a fluorogenic substrate of caspase-8 and possesses amino aicd sequence IETD which is recognized by caspase-8-mediated proteolysis. It is also a substrate for caspase-3 processing enzyme, caspase-10, and granzyme B.

Ac-VDVAD-AFC
A8757-1 1 mg
EUR 145

Ac-VDVAD-AFC
A8757-10 10 mg
EUR 529

Ac-VDVAD-AFC
A8757-5 5 mg
EUR 313

Ac-LEVD-AFC
A8759-25 25 mg
EUR 456

Ac-LEVD-AFC
A8759-5 5 mg
EUR 166

Ac-WEHD-AFC
A8761-1 1 mg
EUR 145

Ac-WEHD-AFC
A8761-10 10 mg
EUR 483

Ac-WEHD-AFC
A8761-5 5 mg
EUR 290

Ac-YVAD-AFC
A8956-10 10 mg
EUR 293
Description: Ac-YVAD-AFC

Ac-YVAD-AFC
A8956-5 5 mg
EUR 180
Description: Ac-YVAD-AFC

Ac-Gly-Pro-AFC
I-2000.0005 5.0mg
EUR 200
Description: Sum Formula: C19H18F3N3O5; CAS# [886993-02-8]

Ac-Gly-Pro-AFC
I-2000.0025 25.0mg
EUR 708
Description: Sum Formula: C19H18F3N3O5; CAS# [886993-02-8]

Ac-Gly-Pro-AFC
I-2000.0100 100.0mg
EUR 2061
Description: Sum Formula: C19H18F3N3O5; CAS# [886993-02-8]

Ac-DEVD-CHO, Caspase-3 Inhibitor
10404 5MG
EUR 307
Description: Minimum order quantity: 1 unit of 5MG

Ac-DEVD-CHO, Caspase-3 Inhibitor
10404-1 1MG
EUR 125
Description: Minimum order quantity: 1 unit of 1MG

Ac-Tyr-Val-Ala-Asp-AFC
I-1705.0005 5.0mg
EUR 321
Description: Sum Formula: C33H36F3N5O10; CAS# [219137-85-6]

Ac-Tyr-Val-Ala-Asp-AFC
I-1705.0025 25.0mg
EUR 1192
Description: Sum Formula: C33H36F3N5O10; CAS# [219137-85-6]

Ac-Asp-Glu-Val-Asp-AFC
I-1725.0005 5.0mg
EUR 321
Description: Sum Formula: C30H34F3N5O13; CAS# [201608-14-2]

Ac-Asp-Glu-Val-Asp-AFC
I-1725.0025 25.0mg
EUR 1192
Description: Sum Formula: C30H34F3N5O13; CAS# [201608-14-2]

Ac-Leu-Glu-His-Asp-AFC
I-1820.0001 1.0mg
EUR 116
Description: Sum Formula: C33H38F3N7O11; CAS# [210345-03-2] net

Ac-Leu-Glu-His-Asp-AFC
I-1820.0005 5.0mg
EUR 321
Description: Sum Formula: C33H38F3N7O11; CAS# [210345-03-2] net

Ac-Leu-Glu-His-Asp-AFC
I-1820.0025 25.0mg
EUR 1192
Description: Sum Formula: C33H38F3N7O11; CAS# [210345-03-2] net

Ac-Leu-Glu-Val-Asp-AFC
I-1905.0005 5.0mg
EUR 393
Description: Sum Formula: C32H40F3N5O11; CAS# [1092077-23-0]

Ac-Leu-Glu-Val-Asp-AFC
I-1905.0025 25.0mg
EUR 1482
Description: Sum Formula: C32H40F3N5O11; CAS# [1092077-23-0]

Ac-Leu-Glu-Thr-Asp-AFC
I-1910.0001 1.0mg
EUR 126
Description: Sum Formula: C31H38F3N5O12; CAS# [210345-02-1]

Ac-Leu-Glu-Thr-Asp-AFC
I-1910.0005 5.0mg
EUR 393
Description: Sum Formula: C31H38F3N5O12; CAS# [210345-02-1]

Ac-Lys-Gln-Leu-Arg-AFC
I-2005.0001 1.0mg
EUR 119
Description: Sum Formula: C35H51F3N10O8; CAS# [1802078-38-1] net

Ac-Lys-Gln-Leu-Arg-AFC
I-2005.0005 5.0mg
EUR 323
Description: Sum Formula: C35H51F3N10O8; CAS# [1802078-38-1] net

Ac-Trp-Glu-His-Asp-AFC
I-2010.0001 1.0mg
EUR 71
Description: Sum Formula: C38H37F3N8O11; CAS# [210344-99-3] net

Ac-Trp-Glu-His-Asp-AFC
I-2010.0005 5.0mg
EUR 177
Description: Sum Formula: C38H37F3N8O11; CAS# [210344-99-3] net

Ac-DEVD-AMC *CAS 169332-61-0*
13402 5 mg
EUR 132
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

Ac-DEVD-CHO *CAS 169332-60-9*
13403 1 mg
EUR 132
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

Ac-DEVD-pNA *CAS 189950-66-1*
13405 5 mg
EUR 132
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

Ac-IETD-AFC *CAS 211990-57-7*
13410 5 mg
EUR 219
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

Caspase 3 Substrate 1m (Apopain), fluorogenic; Ac-DEVD-AMC
5-00935 4 x 5mg Ask for price

Caspase 3 Substrate 1m (Apopain), fluorogenic; Ac-DEVD-AMC Peptide
20-abx265595
  • EUR 523.00
  • EUR 286.00
  • EUR 370.00
  • 10 mg
  • 2 mg
  • 5 mg
  • Shipped within 5-10 working days.

Biotin-DEVD-FMK
1124-20C
EUR 370

Z-DEVD-FMK
1143-1
EUR 316

Z-DEVD-FMK
1143-5
EUR 805

Z-DEVD-AMC
13421 5 mg
EUR 176
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

Z-DEVD-pNA
13422 5 mg
EUR 132
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

FITC-DEVD-FMK
9499-100
EUR 359

Z-DEVD-pNA
A8748-25 25 mg
EUR 282
Description: Z-DEVD-pNA is a colorimetric substrate for caspase-3 with increased cell permeability. Sequence is based on PARP poly(ADP-ribose) polymerase which is clevaved by caspase-3 at the amino acid sequence DEVD[1].

Z-DEVD-pNA
A8748-5 5 mg
EUR 119
Description: Z-DEVD-pNA is a colorimetric substrate for caspase-3 with increased cell permeability. Sequence is based on PARP poly(ADP-ribose) polymerase which is clevaved by caspase-3 at the amino acid sequence DEVD[1].

Z-DEVD-FMK
A1920-1 1 mg
EUR 113
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-10 10 mg
EUR 340
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-25 25 mg
EUR 514
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-5 5 mg
EUR 224
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-5.1 10 mM (in 1mL DMSO)
EUR 293
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
A1920-S Evaluation Sample
EUR 81
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK
HY-12466 10mg
EUR 393

H-Ala-AFC
I-1455.0250 250.0mg
EUR 587
Description: Sum Formula: C13H11F3N2O3; CAS# [126910-31-4] net

H-Ala-AFC
I-1455.1000 1.0g
EUR 1698
Description: Sum Formula: C13H11F3N2O3; CAS# [126910-31-4] net

FITC-C6-DEVD-FMK
13406 1 mg
EUR 480
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

FITC-C6-DEVD-FMK
13408 100 ug
EUR 219
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

EZSolution? Q-DEVD-OPh
1178-1
EUR 272

H-Ala-Pro-AFC
I-1680.0050 50.0mg
EUR 563
Description: Sum Formula: C18H18F3N3O4; CAS# [125791-92-6]

H-Ala-Pro-AFC
I-1680.0250 250.0mg
EUR 2159
Description: Sum Formula: C18H18F3N3O4; CAS# [125791-92-6]

AC-PEG-AC
abx085037-10kDa1g 10 kDa; 1 g
EUR 328
  • Shipped within 5-10 working days.

AC-PEG-AC
abx085037-1kDa1g 1 kDa; 1 g
EUR 328
  • Shipped within 5-10 working days.

AC-PEG-AC
abx085037-20kDa1g 20 kDa; 1 g
EUR 328
  • Shipped within 5-10 working days.

Z-DEVD-ProRed™ 620
13433 1 mg
EUR 306
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 12352200

Caspase-3 Substrate DEVD-pNA
1008-1000
EUR 642

Caspase-3 Substrate DEVD-pNA
1008-200
EUR 327

Ac-Tyr(Ac)-OH
5-03625 25g Ask for price

Ac-Tyr(Ac)-OH
5-03626 100g Ask for price

Ac-GPK(Ac)-pNA
5-00556 4 x 5mg Ask for price

Ac-Lys(Ac)-OH
E-1775.0001 1.0g
EUR 126
Description: Sum Formula: C10H18N2O4; CAS# [499-86-5]

Ac-Lys(Ac)-OH
E-1775.0005 5.0g
EUR 418
Description: Sum Formula: C10H18N2O4; CAS# [499-86-5]

AC-PEG-AC,10K
33-HO009009-10K
  • EUR 167.00
  • EUR 399.00
  • 1g
  • 5g
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

AC-PEG-AC,1K
33-HO009009-1K
  • EUR 167.00
  • EUR 399.00
  • 1g
  • 5g
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound.

Ac-Devd-AFC